Summary Clinical Presentation More common in people with darker skin Correlates with the configuration and distribution of the causative inflammatory dermatosis Causes include inflammatory conditions, cutaneous injuries, irritants, or burns Histologic Features Decrease melanin of the basal keratinocytes Upper dermal/submucosal melanophages Sparse superficial lymphohistiocytic inflammation Inflammatory cause may be coexisting Differential Diagnosis Sarcoidosis Lichen sclerosus Hypopigmented mycosis fungoides Hypopigmented extramammary Pagets disease Hypopigmentation after medication Vitiligo Chemical leukoderma Takeaway Essentials Clinical Relevant Pearls Correlates with distribution of the causative inflammatory dermatosis Pathology Interpretation Pearls Decreased melanin of the basal keratinocytes Upper dermal/submucosal melanophages Immunohistochemical/Molecular Findings Fontana-Masson special stain may show decreased melanization of basal keratinocytes Immunohistochemical melanocytic markers (MITF, HMB45, etc.) may show a decreased number of melanocytes Vitiligo Clinical Features Vitiligo, an acquired leukoderma, is one of the most frequent disorders of pigmentation of the skin and is characterized by distinct areas of skin and mucous membranes depigmentation

IV Therapy Glutathione IV Push delivers a powerful antioxidant directly into the bloodstream to support cellular detoxification, immune function, oxidative stress reduction, and healthy aging goals
The subcutaneous injection cycle followed by oral NMN maintenance is the approach our clinic uses to sustain those improvements between active treatment phases
GLOW Mix Peptide Therapy Combines BPC-157, TB-500, and GHK-Cu into one physician-formulated regenerative blend designed to support faster recovery, reduce inflammation, improve mobility, and enhance skin appearance
7,33 This may be due to vitamin Cs ability to reduce oxidative stress, preventing cellular and DNA damage that may be associated with the development of gastric cancer
Omzo vs